img

Global Alzheimer Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Alzheimer Market Research Report 2024

Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
According to MRAResearch’s new survey, global Alzheimer market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alzheimer market research.
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Alzheimer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Drug Type
Cholinesterase inhibitors
Pipeline Drugs
NMDA receptor antagonist

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Sales
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Alzheimer report covers below items
Chapter 1Product Basic Information (Definition, Drug Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Drug Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Drug Type
1.2.1 Global Alzheimer Market Size Growth Rate by Drug Type: 2018 VS 2022 VS 2033
1.2.2 Cholinesterase inhibitors
1.2.3 Pipeline Drugs
1.2.4 NMDA receptor antagonist
1.3 Market by Application
1.3.1 Global Alzheimer Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer Market Perspective (2018-2033)
2.2 Alzheimer Growth Trends by Region
2.2.1 Global Alzheimer Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Alzheimer Historic Market Size by Region (2018-2023)
2.2.3 Alzheimer Forecasted Market Size by Region (2024-2033)
2.3 Alzheimer Market Dynamics
2.3.1 Alzheimer Industry Trends
2.3.2 Alzheimer Market Drivers
2.3.3 Alzheimer Market Challenges
2.3.4 Alzheimer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer Players by Revenue
3.1.1 Global Top Alzheimer Players by Revenue (2018-2023)
3.1.2 Global Alzheimer Revenue Market Share by Players (2018-2023)
3.2 Global Alzheimer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer Revenue
3.4 Global Alzheimer Market Concentration Ratio
3.4.1 Global Alzheimer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Revenue in 2022
3.5 Alzheimer Key Players Head office and Area Served
3.6 Key Players Alzheimer Product Solution and Service
3.7 Date of Enter into Alzheimer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer Breakdown Data by Drug Type
4.1 Global Alzheimer Historic Market Size by Drug Type (2018-2023)
4.2 Global Alzheimer Forecasted Market Size by Drug Type (2024-2033)
5 Alzheimer Breakdown Data by Application
5.1 Global Alzheimer Historic Market Size by Application (2018-2023)
5.2 Global Alzheimer Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Alzheimer Market Size (2018-2033)
6.2 North America Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Alzheimer Market Size by Country (2018-2023)
6.4 North America Alzheimer Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer Market Size (2018-2033)
7.2 Europe Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Alzheimer Market Size by Country (2018-2023)
7.4 Europe Alzheimer Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer Market Size (2018-2033)
8.2 Asia-Pacific Alzheimer Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Alzheimer Market Size by Region (2018-2023)
8.4 Asia-Pacific Alzheimer Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer Market Size (2018-2033)
9.2 Latin America Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Alzheimer Market Size by Country (2018-2023)
9.4 Latin America Alzheimer Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer Market Size (2018-2033)
10.2 Middle East & Africa Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Alzheimer Market Size by Country (2018-2023)
10.4 Middle East & Africa Alzheimer Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Alzheimer Introduction
11.1.4 Allergan Revenue in Alzheimer Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer Introduction
11.2.4 Eisai Revenue in Alzheimer Business (2018-2023)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer Introduction
11.3.4 Novartis Revenue in Alzheimer Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Alzheimer Introduction
11.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2018-2023)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Detail
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Alzheimer Introduction
11.5.4 Merz Pharma Revenue in Alzheimer Business (2018-2023)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Alzheimer Introduction
11.6.4 Pfizer Revenue in Alzheimer Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Alzheimer Introduction
11.7.4 Johnson & Johnson Revenue in Alzheimer Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Detail
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Alzheimer Introduction
11.8.4 Lundbeck Revenue in Alzheimer Business (2018-2023)
11.8.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Alzheimer Market Size Growth Rate by Drug Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cholinesterase inhibitors
Table 3. Key Players of Pipeline Drugs
Table 4. Key Players of NMDA receptor antagonist
Table 5. Global Alzheimer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Alzheimer Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Alzheimer Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Alzheimer Market Share by Region (2018-2023)
Table 9. Global Alzheimer Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Alzheimer Market Share by Region (2024-2033)
Table 11. Alzheimer Market Trends
Table 12. Alzheimer Market Drivers
Table 13. Alzheimer Market Challenges
Table 14. Alzheimer Market Restraints
Table 15. Global Alzheimer Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Alzheimer Market Share by Players (2018-2023)
Table 17. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer as of 2022)
Table 18. Ranking of Global Top Alzheimer Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Alzheimer Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alzheimer Product Solution and Service
Table 22. Date of Enter into Alzheimer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer Market Size by Drug Type (2018-2023) & (US$ Million)
Table 25. Global Alzheimer Revenue Market Share by Drug Type (2018-2023)
Table 26. Global Alzheimer Forecasted Market Size by Drug Type (2024-2033) & (US$ Million)
Table 27. Global Alzheimer Revenue Market Share by Drug Type (2024-2033)
Table 28. Global Alzheimer Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Alzheimer Revenue Market Share by Application (2018-2023)
Table 30. Global Alzheimer Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Alzheimer Revenue Market Share by Application (2024-2033)
Table 32. North America Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Alzheimer Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Alzheimer Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Alzheimer Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Alzheimer Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Alzheimer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Alzheimer Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Alzheimer Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Alzheimer Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Alzheimer Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Alzheimer Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Alzheimer Market Size by Country (2024-2033) & (US$ Million)
Table 47. Allergan Company Detail
Table 48. Allergan Business Overview
Table 49. Allergan Alzheimer Product
Table 50. Allergan Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. Eisai Company Detail
Table 53. Eisai Business Overview
Table 54. Eisai Alzheimer Product
Table 55. Eisai Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 56. Eisai Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Alzheimer Product
Table 60. Novartis Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Daiichi Sankyo Company Detail
Table 63. Daiichi Sankyo Business Overview
Table 64. Daiichi Sankyo Alzheimer Product
Table 65. Daiichi Sankyo Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 66. Daiichi Sankyo Recent Development
Table 67. Merz Pharma Company Detail
Table 68. Merz Pharma Business Overview
Table 69. Merz Pharma Alzheimer Product
Table 70. Merz Pharma Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 71. Merz Pharma Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Alzheimer Product
Table 75. Pfizer Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Johnson & Johnson Company Detail
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Alzheimer Product
Table 80. Johnson & Johnson Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Lundbeck Company Detail
Table 83. Lundbeck Business Overview
Table 84. Lundbeck Alzheimer Product
Table 85. Lundbeck Revenue in Alzheimer Business (2018-2023) & (US$ Million)
Table 86. Lundbeck Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer Market Size Comparison by Drug Type (2023-2033) & (US$ Million)
Figure 2. Global Alzheimer Market Share by Drug Type: 2022 VS 2033
Figure 3. Cholinesterase inhibitors Features
Figure 4. Pipeline Drugs Features
Figure 5. NMDA receptor antagonist Features
Figure 6. Global Alzheimer Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Alzheimer Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Sales Case Studies
Figure 11. Alzheimer Report Years Considered
Figure 12. Global Alzheimer Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Alzheimer Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Alzheimer Market Share by Region: 2022 VS 2033
Figure 15. Global Alzheimer Market Share by Players in 2022
Figure 16. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Alzheimer Revenue in 2022
Figure 18. North America Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Alzheimer Market Share by Country (2018-2033)
Figure 20. United States Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Alzheimer Market Share by Country (2018-2033)
Figure 24. Germany Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer Market Share by Region (2018-2033)
Figure 32. China Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Alzheimer Market Share by Country (2018-2033)
Figure 40. Mexico Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer Market Share by Country (2018-2033)
Figure 44. Turkey Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Alzheimer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Allergan Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 47. Eisai Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 49. Daiichi Sankyo Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 50. Merz Pharma Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 51. Pfizer Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 53. Lundbeck Revenue Growth Rate in Alzheimer Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed